Results
1 -
10 of
25Clinical Use of Serum Biomarkers in the Prediction of Cardiovascular Risk, Coronary Artery Disease Phospholipases in Cardiovascular Disease, Phospholipases in Health and Disease Pathophysiological Aspects of Lipoprotein-Associated Phospholipase A2: A Brief Overview, Phospholipases in Health and Disease Nonsynonymous polymorphisms in PLA2G7 gene are associated with the risk of coronary heart disease in a southern Chinese population, Mammalian Genome Gene expression signatures of angiocidin and darapladib treatment connect to therapy options in cervical cancer, Journal of Cancer Research and Clinical Oncology Is size really all that matters? Remarks on size and necrotic core content of atherosclerotic plaques, The International Journal of Cardiovascular Imaging Lp-PLA2 Inhibitors for the Reduction of Cardiovascular Events, Cardiology and Therapy Lipoprotein associated phospholipase A2: role in atherosclerosis and utility as a biomarker for cardiovascular risk, EPMA Journal Role of Vascular Inflammation in Coronary Artery Disease: Potential of Anti-inflammatory Drugs in the Prevention of Atherothrombosis, American Journal of Cardiovascular Drugs Geneticsu2014Current and Future Role in the Prevention and Management of Coronary Artery Disease, Current Atherosclerosis Reports